The term "G6PD4 Antibody" does not appear in peer-reviewed literature or commercial antibody databases as of March 2025. This may reflect a misnomer or a reference to specific anti-G6PD antibodies (e.g., NB100-236, MAB11467) used in research. Below, we analyze G6PD-targeting antibodies and their applications, supported by experimental data and clinical insights.
G6PD (Glucose-6-phosphate dehydrogenase) is a key enzyme in the pentose phosphate pathway (PPP), critical for NADPH production, redox balance, and immune cell function . Antibodies against G6PD are used to study its expression, activity, and role in diseases like G6PD deficiency or autoimmune disorders.
| Antibody Catalog Number | Application | Target Species | Detection Method |
|---|---|---|---|
| NB100-236 (Bio-Techne) | Western blot, immunoprecipitation | Human, mouse | Chemiluminescence |
| MAB11467 (R&D Systems) | Western blot, Simple Western™ | Human | HRP-conjugated secondary antibodies |
NB100-236: Detects a ~59 kDa band in human (HeLa, 293T) and mouse (NIH3T3) cell lysates .
MAB11467: Identifies a ~58–59 kDa band in A549 (lung), MCF-7 (breast), and Jurkat (T-cell) cells .
G6PD deficiency (common in populations of African, Asian, and Mediterranean descent) is linked to increased risks of autoimmune disorders and infections. Antibodies like NB100-236 are used to correlate G6PD activity with disease severity.
G6PD deficiency reduces NADPH, impairing redox balance and increasing oxidative stress in immune cells .
In neutrophils and macrophages, G6PD activity is critical for reactive oxygen species (ROS) production during phagocytosis .
Human Samples: Detects G6PD in HeLa (50 µg lysate) and 293T cells .
Mouse Samples: Confirms G6PD expression in NIH3T3 cells via immunoprecipitation .
Specificity: No cross-reactivity reported; validated for cytosolic extracts .
Sensitivity: Detects G6PD at 1 µg/ml in A549 and MCF-7 lysates .
Simple Western™: Identifies G6PD at 58 kDa in Jurkat T-cells .
| Population | Sex | Reference Interval (U/g Hb) | Clinical Decision Limits (CDLs) |
|---|---|---|---|
| Guangzhou, China | Male | 11.20–20.04 | <10% NMM (high hemolysis risk) |
| Guangzhou, China | Female | 12.29–23.16 | <30% NMM (high hemolysis risk) |
Note: NMM = Normal Male Median (15.51 U/g Hb). CDLs help identify individuals with G6PD variants requiring genetic testing .
| Serology Test | Odds Ratio (G6PD Deficient vs. Controls) |
|---|---|
| Antinuclear antibodies | 1.81 (p < 0.001) |
| Anti-Smith antibodies | 5.00 (p = 0.020) |
| Anti-RNP-68 antibodies | 4.00 (p = 0.007) |
G6PD4 is a catalytically inactive isoform of glucose-6-phosphate dehydrogenase that plays a significant role in protein-protein interactions. Unlike active G6PD enzymes that catalyze the first step in the pentose phosphate pathway, G6PD4 functions primarily as a regulatory protein. Research indicates that G6PD4 evolved to become a cytosolic redox switch that confers thioredoxin-relayed alternative targeting to peroxisomes . When developing experimental systems to study G6PD4, researchers should consider its interactions with G6PD1 and thioredoxin m2 (Trx m2) as these are critical for understanding its biological function .
Methodologically, researchers studying G6PD4 should implement bimolecular fluorescence complementation (BiFC) assays to visualize protein-protein interactions in living cells, as this technique has successfully demonstrated G6PD4's interactions with other proteins in previous studies .
G6PD4 antibodies must be highly specific to discriminate between the catalytically inactive G6PD4 and other active G6PD isoforms like G6PD1. The key methodological consideration is epitope selection, as G6PD4 shares sequence homology with other G6PD family members while containing unique regions involved in protein-protein interactions .
When selecting or developing G6PD4-specific antibodies, researchers should target regions containing redox-sensitive cysteines that are conserved in G6PD4 but differ from other isoforms. These cysteine residues are critical for G6PD4's interaction with G6PD1 and subsequent peroxisomal targeting . Validation should include cross-reactivity testing against multiple G6PD isoforms to ensure specificity.
Sample preparation for G6PD4 antibody applications requires careful consideration of protein-protein interactions and cellular localization. Based on G6PD research methods, effective sample preparation should maintain protein complexes when studying interactions while allowing for specific detection of G6PD4.
For immunofluorescence applications, fixation methods should preserve protein-protein interactions. A recommended protocol includes:
Fixation with 4% paraformaldehyde for 15-20 minutes at room temperature
Gentle permeabilization with 0.1-0.3% Triton X-100 to maintain protein complexes
Blocking with 1-5% BSA to reduce background signal
Antibody dilution ranging from 1:50-1:500 for optimal staining
For flow cytometry applications, use approximately 0.40 μg of antibody per 10^6 cells in a 100 μl suspension . Cell permeabilization is critical as G6PD4 is an intracellular protein.
Validation of G6PD4 antibodies requires multi-parameter experimental design. A comprehensive validation approach should include:
Specificity Testing: Compare reactivity with recombinant G6PD4 versus other G6PD isoforms, particularly G6PD1.
Cellular Expression Verification: Use cells known to express G6PD4 (based on previous studies of Arabidopsis and other model systems) as positive controls .
Knockout/Knockdown Controls: When possible, use CRISPR/Cas9 edited cell lines lacking G6PD4 expression as negative controls.
Application-Specific Validation:
Cross-Reactivity Assessment: Test reactivity across species (such as human and mouse samples) to determine conservation of recognized epitopes .
Detection of G6PD4-protein interactions requires techniques that preserve native protein complexes. Based on previous G6PD research, the following methodological approaches are recommended:
Co-Immunoprecipitation (Co-IP): Use G6PD4 antibodies conjugated to agarose or magnetic beads to pull down G6PD4 along with interacting partners. Western blotting can then confirm the presence of known interaction partners like G6PD1 or Trx m2 .
Proximity Ligation Assay (PLA): This technique can detect protein interactions with high sensitivity when proteins are within 40 nm of each other, making it ideal for detecting G6PD4-G6PD1 interactions in fixed cells.
Bimolecular Fluorescence Complementation (BiFC): This in vivo approach has been successfully used to demonstrate that G6PD4-G6PD1 interaction results in peroxisomal import . It involves tagging potential interaction partners with complementary fragments of a fluorescent protein.
Förster Resonance Energy Transfer (FRET): Use fluorescently labeled antibodies against G6PD4 and its interaction partners to detect energy transfer when proteins are in close proximity.
Each of these techniques requires careful optimization of antibody concentrations, incubation times, and buffer conditions to minimize background while maximizing specific signal.
When investigating G6PD4 subcellular localization using antibodies, several controls are methodologically critical:
Organelle Markers: Include established markers for cytosol, peroxisomes, and plastids, as G6PD4 has been shown to interact with proteins targeting these compartments .
Interaction-Deficient Mutants: Create or use G6PD4 mutants with serine replacements of redox-sensitive cysteines which abolish the G6PD4-G6PD1 interaction . These should show altered localization patterns compared to wild-type protein.
Co-expression Controls: When studying G6PD4 localization through protein-protein interactions, include controls where G6PD4 is expressed alone versus co-expressed with interaction partners like G6PD1 or Trx m2 .
Fixation Controls: Compare results using different fixation methods, as some may disrupt protein-protein interactions and affect observed localization patterns.
Antibody Specificity Controls: Include secondary antibody-only controls and isotype controls to confirm specificity of observed localization patterns.
Variable G6PD4 staining patterns may reflect biological reality rather than technical artifacts. When interpreting such data:
Quantify Subcellular Distribution: Use image analysis software to quantify the proportion of G6PD4 signal in different cellular compartments across cell types. Previous research shows that G6PD4 can localize to peroxisomes upon interaction with G6PD1, but remains cytosolic when bound to Trx m2 .
Correlate with Expression Levels of Interaction Partners: Analyze whether differences in localization correlate with expression levels of known interaction partners (G6PD1, Trx m2). The balance of these interactions determines the ultimate localization of G6PD4 .
Consider Redox State: Since G6PD4 interactions involve redox-sensitive cysteines , different cellular redox environments may affect observed localization patterns.
Validate with Multiple Detection Methods: Compare staining patterns obtained using different fixation methods, antibody clones, and detection techniques (e.g., compare immunofluorescence results with subcellular fractionation followed by Western blotting).
For visualization techniques, dilutions of 1:50-1:500 for immunofluorescence applications should be tested to determine optimal signal-to-noise ratio in different cell types .
Contradictory G6PD4 expression data between methods requires systematic investigation:
Epitope Accessibility Analysis: Different antibodies may recognize epitopes with varying accessibility depending on G6PD4's conformation or interaction state. Test multiple antibodies targeting different regions of G6PD4.
Sample Preparation Impact: Compare native versus denatured sample preparation. For instance, flow cytometry typically detects native proteins (0.40 μg antibody per 10^6 cells) , while Western blotting detects denatured proteins.
Fixation Method Comparison: Systematically compare different fixation protocols, as some may preserve certain protein-protein interactions better than others, affecting epitope accessibility.
Expression Level Quantification: Implement absolute quantification methods like quantitative flow cytometry with calibration beads or quantitative mass spectrometry to determine actual G6PD4 expression levels.
Transcript-Protein Correlation: Compare protein expression data with RNA expression data (RT-qPCR or RNA-seq) to identify potential post-transcriptional regulation mechanisms.
Distinguishing specific from non-specific G6PD4 antibody signals requires rigorous controls:
Titration Experiments: Perform antibody titration experiments (1:50-1:500 for immunofluorescence) to identify optimal concentrations where specific signal is maximized and background is minimized.
Competitive Binding Assays: Pre-incubate G6PD4 antibodies with recombinant G6PD4 protein before staining to competitively inhibit specific binding.
Genetic Controls: When possible, use G6PD4 knockout/knockdown cells to establish baseline non-specific binding levels.
Cross-Adsorption: For polyclonal antibodies, consider cross-adsorption against other G6PD isoforms to remove antibodies that might cross-react.
Multiple Antibody Validation: Compare staining patterns obtained with different antibody clones targeting distinct G6PD4 epitopes. Consistent patterns across different antibodies suggest specific detection.
Signal-to-Noise Quantification: Implement quantitative image analysis to calculate signal-to-noise ratios across different experimental conditions.
Studying G6PD4's cysteine-dependent interactions requires methods that preserve redox-sensitive protein interactions:
Site-Directed Mutagenesis Combined with Interaction Assays: Generate serine replacements of redox-sensitive cysteines in G6PD4 that have been shown to abolish G6PD4-G6PD1 interaction . Use these in conjunction with protein-protein interaction assays.
Redox-Preserving Co-IP: Perform co-immunoprecipitation with buffers containing N-ethylmaleimide to alkylate free thiols and prevent artificial disulfide formation during sample preparation.
Diagonal Redox SDS-PAGE: This two-dimensional electrophoresis technique can identify proteins bound to G6PD4 via disulfide bonds under different cellular redox conditions.
Quantitative Redox Proteomics: Use mass spectrometry-based approaches to identify and quantify the oxidation status of cysteine residues in G6PD4 under different conditions.
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): This technique can map protein-protein interaction interfaces and conformational changes that occur upon G6PD4 binding to partners like G6PD1 or Trx m2 .
In vivo Redox Imaging: Combine G6PD4 antibody staining with redox-sensitive fluorescent probes to correlate G6PD4 localization with cellular redox state.
G6PD4 antibodies can help elucidate novel protein targeting mechanisms as exemplified by research showing G6PD4-mediated alternative targeting of G6PD1 to peroxisomes :
Dual-Color Immunofluorescence: Combine G6PD4 antibodies with antibodies against organelle markers and potential interaction partners to track changes in protein localization under different cellular conditions.
Protein Transport Kinetics: Use pulse-chase experiments with G6PD4 antibodies to track the movement of G6PD4 and its binding partners between cellular compartments over time.
In vitro Reconstitution Assays: Develop cell-free systems using purified organelles (peroxisomes, plastids) and recombinant proteins to study how G6PD4 interactions affect protein import into specific organelles.
Structure-Function Analysis: Use G6PD4 antibodies to analyze how mutations in potential targeting signals (like the internal PTS1-like signal SKY identified in G6PD1) affect localization and interaction patterns.
Interactome Analysis: Employ G6PD4 antibodies for immunoprecipitation followed by mass spectrometry to identify novel interaction partners that may be involved in alternative targeting mechanisms.
G6PD4's involvement in redox-sensitive processes requires specialized methodological approaches:
Redox State Manipulation: Combine G6PD4 immunostaining with controlled cellular redox state manipulation (oxidants, antioxidants, or metabolic perturbations) to observe changes in G6PD4 localization and interactions.
Multiparameter Flow Cytometry: Use G6PD4 antibodies (0.40 μg per 10^6 cells) in conjunction with redox-sensitive dyes and markers of oxidative stress to correlate G6PD4 expression with cellular redox status at the single-cell level.
Thiol-Trapping Techniques: Employ thiol-reactive probes to quantify the oxidation state of redox-sensitive cysteines in G6PD4 under different cellular conditions.
CRISPR-Based Functional Screens: Create cellular systems where G6PD4 expression or specific cysteine residues are modified to assess functional consequences on redox homeostasis and stress responses.
Bioinformatic Analysis: Compare G6PD4 sequence and function across species to identify conserved redox-sensitive motifs that may be targeted by antibodies for functional studies.
Crosstalk with Pentose Phosphate Pathway: Investigate how G6PD4 (catalytically inactive) affects the function of active G6PD isoforms in the pentose phosphate pathway, which is critical for generating NADPH for cellular redox balance. By implementing these methodological approaches and carefully designing experiments with appropriate controls, researchers can effectively utilize G6PD4 antibodies to advance our understanding of this protein's complex roles in cellular biochemistry and redox regulation.